iNova Pharmaceuticals Names Sarvesh Sahni Marketing Director for Skincare and Women's Health Across AMENA

Introduction

In the global consumer healthcare and pharmaceutical marketing landscape, few appointments signal strategic intent as clearly as hiring a former Johnson and Johnson and Kenvue marketing director to lead a multi-region skincare and women's health portfolio. iNova Pharmaceuticals has done exactly that. As the company looks to accelerate growth across some of its most recognised dermatology and women's health brands, the arrival of Sarvesh Sahni brings a combination of global brand-building depth and category expertise that is rarely found in a single profile.

The Big Announcement

iNova Pharmaceuticals has appointed Sarvesh Sahni as Marketing Director for Skincare and Women's Health, covering the AMENA region — Asia, Europe, the Middle East, and North Africa. He is based in Singapore, reflecting the strategic importance of the Asia-Pacific hub for the company's regional operations.

In his new capacity, Sahni will lead brand strategy and growth initiatives across iNova's skincare and women's health portfolio, which includes globally recognised names such as Betadine, Dermaveen, and Acne-Aid. His remit spans category leadership, innovation pipelines, portfolio expansion, and new growth opportunity development across a geographically diverse and commercially significant multi-region mandate.

Sahni announced the appointment on LinkedIn, describing the role as one that brings together his core professional interests — science-backed brand building, meaningful product innovation, and culturally relevant marketing strategy across diverse consumer markets.

Prior to joining iNova, Sahni spent a significant tenure at Kenvue — the consumer health company spun out of Johnson and Johnson — where he served as Global Marketing Director for Hydration and Nutritionals. He also held regional and category marketing roles across baby care, feminine care, and brand marketing within the broader J&J ecosystem. Earlier in his career, he built a strategic consulting foundation at Deloitte Consulting.

What This Means for Your Brand

This appointment carries meaningful signals for marketing professionals and brand strategists operating within consumer healthcare, pharmaceutical marketing, and the broader skincare category.

One — the AMENA mandate is a complex, high-stakes brief. Managing brand strategy across Asia, Europe, the Middle East, and North Africa simultaneously demands an unusually high degree of cultural fluency. Consumer attitudes toward skincare, women's health, and pharmaceutical brands vary enormously across these geographies — from the science-first orientation of European markets to the beauty-health convergence driving skincare growth across Southeast Asia and the rising health awareness reshaping demand across the Middle East and North Africa. A leader who can hold that complexity without defaulting to a one-size-fits-all global template is a rare and valuable asset.

Two — iNova's portfolio choices reveal its ambitions. Betadine is a globally trusted antiseptic and wound care brand with strong pharmacy equity. Dermaveen is a dermatologist-recommended skincare range with a loyal following in Australia and growing regional presence. Acne-Aid is a clinically positioned acne care brand with strong credibility across Asian markets. Together, these represent a portfolio at the intersection of pharmaceutical trust and consumer skincare aspiration — a space experiencing significant commercial momentum globally.

Three — Sahni's Kenvue and J&J background is precisely the pedigree this kind of role requires. Large consumer healthcare companies like J&J operate at the highest standards of brand governance, regulatory compliance, and multi-market marketing rigour. Leaders who have navigated that environment bring discipline and frameworks that smaller pharmaceutical companies can leverage to professionalise and scale their marketing operations rapidly.

Expert Take

Sahni's own framing of the role is instructive. He described his focus as sitting at the convergence of trusted science, meaningful innovation, and culturally relevant brand-building — a positioning that reflects how the most sophisticated consumer healthcare marketers now think about their work.

The days of pharmaceutical and OTC brands relying purely on clinical claims and pharmacy push strategies are giving way to a more nuanced model — one where brand equity, consumer trust, and emotional relevance work alongside efficacy credentials to drive preference and loyalty. This shift is particularly pronounced in skincare, where the boundary between pharmaceutical and beauty has become increasingly permeable.

India is a relevant market within Sahni's AMENA mandate, and the skincare and women's health categories here are experiencing strong growth driven by rising awareness, increasing premiumisation, and expanding digital and quick commerce distribution. How iNova positions its portfolio brands for Indian consumers will be a story worth following closely.

The brands.in Perspective

Sarvesh Sahni's move from a global consumer healthcare giant to a specialist pharmaceutical company with strong regional ambitions is a pattern worth noting. Increasingly, the most compelling career moves in Indian and Asian marketing are not always upward in the conventional sense — they are lateral moves into organisations where the scope to shape strategy is broader and the impact more visible. iNova gains not just a marketing director but an architect — someone expected to build category leadership, not simply maintain it. In consumer healthcare, that distinction matters enormously.

Key Takeaways for Marketers

• Sarvesh Sahni joins iNova Pharmaceuticals as Marketing Director for Skincare and Women's Health, AMENA region
• Portfolio includes globally recognised brands Betadine, Dermaveen, and Acne-Aid
• He brings extensive Kenvue and Johnson and Johnson global marketing experience to the role
• AMENA mandate spans Asia, Europe, Middle East, and North Africa from a Singapore base
• Appointment reflects iNova's intent to professionalise and scale its multi-region brand strategy

FAQ

What is Sarvesh Sahni's new role at iNova Pharmaceuticals? He has joined as Marketing Director for Skincare and Women's Health across the AMENA region — covering Asia, Europe, the Middle East, and North Africa — based in Singapore, with responsibility for brands including Betadine, Dermaveen, and Acne-Aid.

What was Sarvesh Sahni's background before iNova? Sahni was previously Global Marketing Director for Hydration and Nutritionals at Kenvue, formerly part of Johnson and Johnson, where he also held regional roles across baby care, feminine care, and brand marketing. He began his career at Deloitte Consulting.

What brands does iNova Pharmaceuticals market in the skincare and women's health space? iNova's key skincare and women's health brands include Betadine, a globally trusted antiseptic and wound care brand, Dermaveen, a dermatologist-recommended skincare range, and Acne-Aid, a clinically positioned acne care brand with strong presence across Asian markets.

Closing

As consumer healthcare and pharmaceutical marketing converge with the language and expectations of premium skincare, the leaders who can navigate both worlds with equal fluency will define the next decade of brand growth in this space. Sarvesh Sahni's appointment at iNova is a strong signal that the company understands what that future demands.

What do you think is the biggest opportunity for pharmaceutical brands looking to build consumer brand equity in India and Asia? Share your thoughts below — and follow brands.in for daily intelligence on leadership moves, brand strategies, and marketing insights shaping the industry.